• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌。该生物体及其临床相关性。

Campylobacter pylori. The organism and its clinical relevance.

作者信息

Graham D Y, Evans D G, Evans D J

机构信息

Department of Medicine, Baylor College of Medicine, Houston, Texas.

出版信息

J Clin Gastroenterol. 1989;11 Suppl 1:S43-8.

PMID:2809138
Abstract

Campylobacter pylori causes type B gastritis and C. pylori infection has been associated with duodenal ulcer, gastric ulcer, non-ulcer dyspepsia, and gastric cancer. Although we have been able to culture C. pylori for only about 5 years, what we now know about this organism can explain many mysteries surrounding peptic ulcer disease. Whenever one investigates a population of ulcer patients for the presence of any accepted potentially important pathogenetic factors, one finds that the population of patients with duodenal ulcer disease differs (statistically) from those without duodenal ulcer disease, but that to a large degree they also overlap. None of the traditional factors can be considered essential and characteristic of chronic duodenal ulcer. The exception is the presence of a C. pylori infection, the presence of which is almost invariable. Several properties of C. pylori have been identified that might be virulence factors, including (a) provoking a marked acute and chronic inflammatory response, (b) rapid motility through gastric mucus, (c) urease activity, (d) a fibrillar adhesin(s), (e) several putative exotoxins, and (f) microinvasion. We can now add to the old dictum "no acid-no ulcer," "no C. pylori-no ulcer" at least as far as chronic duodenal ulcer disease in adults is concerned.

摘要

幽门螺杆菌可引起B型胃炎,幽门螺杆菌感染与十二指肠溃疡、胃溃疡、非溃疡性消化不良及胃癌相关。虽然我们能够培养幽门螺杆菌的时间仅约5年,但我们目前对这种微生物的了解可以解释许多围绕消化性溃疡病的谜团。每当有人调查溃疡患者群体中是否存在任何公认的潜在重要致病因素时,都会发现十二指肠溃疡病患者群体与无十二指肠溃疡病患者群体(在统计学上)存在差异,但在很大程度上他们也有重叠。没有任何传统因素可被视为慢性十二指肠溃疡的必要和特征性因素。唯一的例外是幽门螺杆菌感染的存在,其存在几乎是恒定不变的。已确定幽门螺杆菌的几种特性可能是毒力因子,包括(a)引发明显的急性和慢性炎症反应,(b)通过胃黏液快速运动,(c)尿素酶活性,(d)一种或多种纤维状黏附素,(e)几种假定的外毒素,以及(f)微侵袭。就成人慢性十二指肠溃疡病而言,我们现在可以在古老的格言“无酸无溃疡”之外再加上“无幽门螺杆菌无溃疡”。

相似文献

1
Campylobacter pylori. The organism and its clinical relevance.幽门螺杆菌。该生物体及其临床相关性。
J Clin Gastroenterol. 1989;11 Suppl 1:S43-8.
2
[Campylobacter pylori in patients with gastroduodenal disease].[胃十二指肠疾病患者中的幽门螺杆菌]
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 1):575-88.
3
Campylobacter pylori: a newly recognized infectious agent in the gastrointestinal tract.
Am J Surg Pathol. 1988;12 Suppl 1:89-99.
4
[Campylobacter pylori: cause of gastritis and ulcer disease?].
Schweiz Med Wochenschr. 1988 Apr 23;118(16):577-83.
5
Campylobacter pylori and its role in peptic ulcer disease.
Gastroenterol Clin North Am. 1990 Mar;19(1):183-96.
6
[Is Campylobacter pylori the pathogenic agent in gastritis and peptic ulcer?].
Vnitr Lek. 1989 Jul;35(7):672-8.
7
[Antibacterial treatment of Campylobacter pylori-associated gastritis and peptic ulcer].幽门螺杆菌相关性胃炎和消化性溃疡的抗菌治疗
Ugeskr Laeger. 1989 Apr 24;151(17):1030-3.
8
[The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice].[幽门螺杆菌感染在胃肠病学和糖尿病诊疗中的意义]
Orv Hetil. 1989 Jun 18;130(25):1325-9.
9
Long-term consequences of Helicobacter pylori eradication.幽门螺杆菌根除的长期后果。
Scand J Gastroenterol Suppl. 1994;205:38-44.
10
[Presence of Campylobacter pylori in the gastric mucosa of healthy persons and in patients with peptic ulcer and non-ulcer dyspepsia].
Pol Tyg Lek. 1988 Aug 29;43(35):1111-3.

引用本文的文献

1
Comparative analysis of anti-Helicobacter pylori activities of FEMY-R7 composed of Laminaria japonica and Oenothera biennis extracts in mice and humans.由海带和月见草提取物组成的FEMY-R7对小鼠和人类抗幽门螺杆菌活性的比较分析。
Lab Anim Res. 2015 Mar;31(1):7-12. doi: 10.5625/lar.2015.31.1.7. Epub 2015 Mar 20.
2
Anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans.由岩藻依聚糖和月见草提取物组成的FEMY-R7对小鼠和人类的抗幽门螺杆菌活性。
Lab Anim Res. 2014 Sep;30(3):131-5. doi: 10.5625/lar.2014.30.3.131. Epub 2014 Sep 29.
3
In vitro and in vivo anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract.
由岩藻依聚糖和月见草提取物组成的FEMY-R7的体外和体内抗幽门螺杆菌活性
Lab Anim Res. 2014 Mar;30(1):28-34. doi: 10.5625/lar.2014.30.1.28. Epub 2014 Mar 24.
4
Anti-Helicobacter pylori effects of IgY from egg york of immunized hens.免疫母鸡蛋黄中提取的免疫球蛋白Y(IgY)对幽门螺杆菌的作用。
Lab Anim Res. 2012 Mar;28(1):55-60. doi: 10.5625/lar.2012.28.1.55. Epub 2012 Mar 21.
5
DNA-DNA hybridization demonstrates apparent genetic differences between Helicobacter pylori from patients with duodenal ulcer and asymptomatic gastritis.DNA-DNA杂交显示十二指肠溃疡患者与无症状性胃炎患者的幽门螺杆菌之间存在明显的基因差异。
Dig Dis Sci. 1993 Jun;38(6):1128-31. doi: 10.1007/BF01295731.
6
Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology.幽门螺杆菌与胃癌:与胃炎、肠化生及肿瘤组织学的相关性
Gut. 1992 Aug;33(8):1029-32. doi: 10.1136/gut.33.8.1029.